Safety and tolerability of intramuscular sotrovimab administered at different injection sites: results from the Phase 1 COSMIC study
Safety and tolerability of intramuscular sotrovimab administered at different injection sites: results from the Phase 1 COSMIC study is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Safety and tolerability of intramuscular sotrovimab administered at different injection sites: results from the Phase 1 COSMIC study have?
Safety and tolerability of intramuscular sotrovimab administered at different injection sites: results from the Phase 1 COSMIC study has 1 citations in the OpenAlex counts ScholarIQ stores.
When was Safety and tolerability of intramuscular sotrovimab administered at different injection sites: results from the Phase 1 COSMIC study published?
Safety and tolerability of intramuscular sotrovimab administered at different injection sites: results from the Phase 1 COSMIC study has 2025 year in the ScholarIQ index.
What is the open-access status of Safety and tolerability of intramuscular sotrovimab administered at different injection sites: results from the Phase 1 COSMIC study?
Safety and tolerability of intramuscular sotrovimab administered at different injection sites: results from the Phase 1 COSMIC study has gold oa status in the ScholarIQ index.
What is the DOI of Safety and tolerability of intramuscular sotrovimab administered at different injection sites: results from the Phase 1 COSMIC study?
The DOI for Safety and tolerability of intramuscular sotrovimab administered at different injection sites: results from the Phase 1 COSMIC study is on the source record.
What is the PMID of Safety and tolerability of intramuscular sotrovimab administered at different injection sites: results from the Phase 1 COSMIC study?
The PMID for Safety and tolerability of intramuscular sotrovimab administered at different injection sites: results from the Phase 1 COSMIC study is on the source record.
What is the OpenAlex record for Safety and tolerability of intramuscular sotrovimab administered at different injection sites: results from the Phase 1 COSMIC study?
The OpenAlex for Safety and tolerability of intramuscular sotrovimab administered at different injection sites: results from the Phase 1 COSMIC study is on the source record.